Top and Current
Source: (remove) : Joseph Schwartz
RSSJSONXMLCSV
Top and Current
Source: (remove) : Joseph Schwartz
RSSJSONXMLCSV
Thu, September 19, 2024
Wed, July 3, 2024
Thu, March 14, 2024
Thu, February 22, 2024
Tue, February 13, 2024
Fri, February 9, 2024
Fri, September 8, 2023
Fri, February 3, 2023
Fri, January 20, 2023
Tue, January 17, 2023
Mon, November 14, 2022
Fri, November 4, 2022
Thu, October 20, 2022
Mon, October 17, 2022
Thu, August 11, 2022
Fri, August 5, 2022
Thu, August 4, 2022
Thu, May 12, 2022
Fri, March 18, 2022
Wed, March 16, 2022
Tue, March 15, 2022
Tue, March 8, 2022
Thu, December 16, 2021
Mon, November 22, 2021
Tue, November 16, 2021
Mon, November 15, 2021
Thu, November 11, 2021
Thu, November 4, 2021
Thu, August 26, 2021
Tue, August 17, 2021
Wed, July 21, 2021
Mon, June 14, 2021
Tue, March 2, 2021
Wed, January 27, 2021
Fri, January 8, 2021
Thu, November 12, 2020
Fri, November 6, 2020
Tue, November 3, 2020
Wed, August 19, 2020
Wed, August 5, 2020
Wed, May 20, 2020
Mon, April 20, 2020
Thu, January 24, 2019
Wed, June 20, 2018
Tue, March 13, 2018
Fri, February 23, 2018
Mon, October 23, 2017
Thu, October 19, 2017
Tue, September 19, 2017
Thu, March 9, 2017
Thu, March 2, 2017
Mon, May 2, 2016
Tue, February 23, 2016
Fri, November 6, 2015
Mon, February 23, 2015
Mon, February 2, 2015
Tue, November 12, 2013
Tue, April 16, 2013
Tue, March 5, 2013

Joseph Schwartz Maintained (APLT) at Buy with Increased Target to $14 on, Sep 19th, 2024


Published on 2024-10-28 14:21:13 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of Leerink Partners, Maintained "Applied Therapeutics, Inc." (APLT) at Buy with Increased Target from $11 to $14 on, Sep 19th, 2024.

Joseph has made no other calls on APLT in the last 4 months.



There are 2 other peers that have a rating on APLT. Out of the 2 peers that are also analyzing APLT, 0 agree with Joseph's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Joseph


  • Tim Lugo of "William Blair" Initiated at Buy on, Wednesday, July 31st, 2024
  • Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $12 on, Wednesday, July 17th, 2024